Robotic Surgery Statistics: 2026 Data

Robotic surgery has moved past the adoption curve. It now represents a dominant and growing share of U.S. surgical volume, with data showing exactly where growth is occurring, which specialties are leading, and what the real per-case costs look like.

Global Robotic Surgery Market Size by Region (2026)

The global surgical robots market is projected to reach $7.6 billion in 2026, up from $6.6 billion in 2025. Grand View Research projects the market to hit $18.5 billion by 2033 at a CAGR of 13.5%. North America holds the largest revenue share at 51.3%, while Asia Pacific carries the highest projected growth rate through 2033.

Region	Global Market Share (2025)	Installed da Vinci Systems (Mid-2025)
North America	51.3%	6,087 (U.S.)
Europe	~25%	2,006
Asia Pacific	~17%	1,854
Rest of World	~7%	541

Key Insights

• North America generates over half of global surgical robotics revenue and has the largest installed base by a wide margin.
• Asia Pacific has 1,854 installed systems and the fastest projected growth through 2033.
• Robotic surgery consumables grow from $5.73B (2025) to $10.9B (2030).
• ASC robotics expands from $180M (2025) to $650M (2034), a 24.2% CAGR.

Robotic Surgery Procedure Adoption by Surgical Specialty

Robotic penetration varies significantly across surgical specialties. Urology leads all categories; more than 87% of U.S. prostatectomies were robotic by 2019, with current penetration exceeding 90%. In general surgery, the use of robotics has grown from 1.8% of procedures in 2012 to between 20% and 30% today. As of January 2026, the American College of Surgeons reports that more than 12 million surgeries have been performed globally using da Vinci systems.

Surgical Specialty	Estimated U.S. Robotic Penetration (2025)	Leading Procedures
Urology	>90%	Radical prostatectomy
Gynecology	25–30%	Hysterectomy, myomectomy
General Surgery	20–30%	Hernia repair, cholecystectomy
Colorectal	25–35%	Colectomy, low anterior resection
Orthopedics	19.8%	Hip and knee replacement
Cardiothoracic	~10–15%	Lobectomy, valve repair

Key Insights

• Urology has effectively completed its transition to robotic surgery—penetration above 90% leaves little room for further growth in that specialty
• General surgery represents the largest remaining growth opportunity, with 20–30% penetration today and projections to double within five years
• Orthopedics holds the largest revenue share of the global surgical robots market at 19.8% in 2025, driven by hip and knee replacement volume
• Cardiothoracic surgery sits at 10–15% penetration, making it one of the least-adopted specialties and a candidate for accelerated uptake as evidence accumulates

Clinical Outcomes: Robotic vs. Laparoscopic vs. Open Surgery

A 2025 study in the Journal of the Society of Laparoscopic & Robotic Surgeons analyzed 19,769 colorectal surgery patients across robotic, laparoscopic, and open approaches. Robotic surgery was associated with the shortest hospital stays, the fewest postoperative complications, and the lowest pain scores across the cohort.

Surgical Outcome	Robotic	Laparoscopic	Open
Average Hospital Stay (Colorectal)	5.6 days	7.9 days	11.2 days
Complication Rate (Colorectal Cancer)	14.1%	—	21.2%
Conversion to Open Surgery	Lowest (meta-analysis)	Moderate	N/A
Readmission Rate	Favorable trend	Moderate	Less favorable
Postoperative Pain	Lowest	Moderate	Highest

Key Insights

• Robotic colorectal patients leave the hospital 2.3 days sooner than laparoscopic patients and 5.6 days sooner than open surgery patients
• The complication rate gap between robotic and open surgery for colorectal cancer stands at 7.1 percentage points, 14.1% vs. 21.2%
• A 20-year meta-analysis published in Annals of Surgery in November 2025 reviewed 360 studies covering 1.57 million patients across 30 countries and found robotic abdominal procedures carry consistently lower rates of conversion to open surgery than laparoscopic approaches
• The conversion advantage held even in patients who were older or carried higher BMI, indicating a platform-level technical benefit rather than case mix effects

Robotic Surgery Cost Breakdown: Systems, Per-Procedure, and Consumables

Robotic surgery costs operate on two levels: capital acquisition and per-case expense. The da Vinci 5 carries a system price of $1.8–$2.5 million, while competing platforms such as Medtronic's Hugo RAS and CMR Surgical's Versius have system prices of $0.75–$1.2 million. Per-procedure costs are estimated at $3,000–$5,000 above laparoscopic equivalents, driven primarily by proprietary instruments and disposable accessories.

Cost Category	Range or Figure	Notes
da Vinci 5 (new system)	$1.8M–$2.5M	Latest generation system (2024 release)
da Vinci Xi (new system)	$1.5M–$2.0M	Most widely deployed model
Competing systems	$0.75M–$1.2M	Includes Hugo and Versius platforms
Per-procedure additional cost	$3,000–$5,000	Increment above laparoscopic procedures
Hospitalization cost premium	~ $2,300 per case	Compared to laparoscopic surgery
Consumables market size (2026)	$6.53B	Growing at ~14% annually
Intuitive recurring revenue share	~85%	From instruments and accessories

Key Insights

• Instruments and accessories represent 85% of Intuitive Surgical's recurring revenue, meaning the ongoing supply cost, not the system price, drives the majority of long-term robotic program spending
• The per-procedure cost premium of $3,000–$5,000 sits on top of an average hospitalization premium of ~$2,300, making total per-case cost elevation a meaningful budget line for high-volume programs
• New pay-per-click pricing models amortize system costs across cases over approximately seven years, lowering the capital barrier for smaller and rural facilities
• Competitive pressure from Medtronic, CMR Surgical, and others is beginning to push both system and instrument pricing downward across the market

Further Reading

• How Much Do Hospitals Spend on Medical Supplies? (2026 Report)
• The Role of Medical Surgical Instruments in Minimally Invasive Surgery
• Reusable vs. Disposable Surgical Instruments: Key Differences
• Surgical Staplers Explained: Types, Uses & Applications
• The Evolution of Surgical Instruments Through History

Request a PDF Copy of This Report

Contact XS Supply today to receive your comprehensive "Robotic Surgery Statistics: 2026 Data" report in PDF format.

XS Supply only purchases from hospitals, surgical centers, and other vetted industry vendors. XS Supply does not purchase personal medical supplies from individuals.